TCG Crossover Management, LLC - Stock Holdings in 13F Filings (SEC)
Updated on March 15, 2026.
Based on 13F Filings filed with the SEC on February 17, 2026, for the 2025 Q4 period, TCG Crossover Management, LLC held in its portfolio 43 assets valued at $3,021,699,270 (i.e. $3.02B).
The most valuable assets in the portfolio included: ABIVAX SA AMERICAN DEPOSITARY SHARES ($959.03M), COGENT BIOSCIENCES INC ($208.44M), and CG ONCOLOGY INC ($152.39M).
The chart below shows the top 10 valuable assets, and the table below shows the top 43 valuable assets.
You can see similar for other investment managers.
Related Topics: SEC Topic List.
Data Source: SEC.
TCG Crossover Management, LLC - Stock Holdings in 13F Filings (SEC)
Items per page:
25
0 of 0
| Name of Issuer | No. of Shares | Value ($) | Class |
|---|---|---|---|
| ABIVAX SA AMERICAN DEPOSITARY SHARES | 7111596 | 959034279 | ADRS |
| COGENT BIOSCIENCES INC | 5868162 | 208437114 | COMM |
| CG ONCOLOGY INC | 3670206 | 152386953 | COMM |
| TANGO THERAPEUTICS INC | 12762094 | 113072153 | COMM |
| CENTESSA PHARMACEUTICALS PLC | 4286480 | 107204865 | ADRS |
| DYNE THERAPEUTICS INC | 4615144 | 90272217 | COMM |
| RAPT THERAPEUTICS INC | 2582408 | 87466159 | COMM |
| TYRA BIOSCIENCES INC | 2898103 | 76191128 | COMM |
| AMYLYX PHARMACEUTICALS INC | 6243812 | 75425249 | COMM |
| SAVARA INC | 12362205 | 74544096 | COMM |
| MONTE ROSA THERAPEUTICS INC | 4622151 | 72475328 | COMM |
| OCULAR THERAPEUTIX INC | 5740231 | 69686404 | COMM |
| DIANTHUS THERAPEUTICS INC | 1676624 | 69093675 | COMM |
| EYEPOINT PHARMACEUTICALS INC | 3572335 | 65266560 | COMM |
| STRUCTURE THERAPEUTICS INC | 920857 | 64045604 | ADRS |
| SPYRE THERAPEUTICS INC | 1900582 | 62263066 | COMM |
| FULCRUM THERAPEUTICS INC | 5250000 | 59377500 | COMM |
| LIQUIDIA TECHNOLOGIES INC | 1710084 | 58980797 | COMM |
| BIOHAVEN LTD | 4631317 | 52287569 | COMM |
| IMMUNOVANT INC | 1660933 | 42220917 | COMM |
| KODIAK SCIENCES INC | 1445538 | 40417243 | COMM |
| ADC THERAPEUTICS SA | 11390175 | 40207318 | COMM |
| LB PHARMACEUTICALS INC | 1745015 | 38844034 | COMM |
| XENCOR INC | 2452138 | 37542233 | COMM |
| REVOLUTION MEDICINES INC | 436473 | 34765074 | COMM |
| AGIOS PHARMACEUTICALS INC | 1181841 | 32169712 | COMM |
| ARVINAS HOLDING CO LLC | 2666216 | 31621322 | COMM |
| RELAY THERAPEUTICS INC | 3220186 | 27242774 | COMM |
| JANUX THERAPEUTICS INC | 1789617 | 24696715 | COMM |
| ENTRADA THERAPEUTICS INC | 2088392 | 21468670 | COMM |
| MBX BIOSCIENCES INC | 650000 | 20501000 | COMM |
| UPSTREAM BIO INC | 743886 | 20196505 | COMM |
| SILENCE THERAPEUTICS PLC | 3033560 | 18444045 | ADRS |
| UROGEN PHARMA LTD | 717347 | 16800267 | COMM |
| ALECTOR INC | 10000000 | 15600000 | COMM |
| MONOPAR THERAPEUTICS INC | 141915 | 9267050 | COMM |
| AVALO THERAPEUTICS INC | 483000 | 8771280 | COMM |
| MAZE THERAPEUTICS INC | 173816 | 7201197 | COMM |
| MIRUM PHARMACEUTICALS INC | 62049 | 4901251 | COMM |
| Athira Pharma, Inc. | 464398 | 3348507 | COMM |
| KORRO BIO INC | 416301 | 3334571 | COMM |
| VENTYX BIOSCIENCES INC | 316195 | 2855241 | COMM |
| VISTAGEN THERAPEUTICS INC | 2676580 | 1771628 | COMM |
Popular Topics:
Find us
Copyright © Beautify Data LLC. All Rights Reserved.